author_facet Protiva, Petr
Mason, Joel B.
Liu, Zhenhua
Hopkins, Michael E.
Nelson, Celeste
Marshall, James R.
Lambrecht, Richard W.
Pendyala, Swaroop
Kopelovich, Levy
Kim, Myungjin
Kleinstein, Steven H.
Laird, Peter W.
Lipkin, Martin
Holt, Peter R.
Protiva, Petr
Mason, Joel B.
Liu, Zhenhua
Hopkins, Michael E.
Nelson, Celeste
Marshall, James R.
Lambrecht, Richard W.
Pendyala, Swaroop
Kopelovich, Levy
Kim, Myungjin
Kleinstein, Steven H.
Laird, Peter W.
Lipkin, Martin
Holt, Peter R.
author Protiva, Petr
Mason, Joel B.
Liu, Zhenhua
Hopkins, Michael E.
Nelson, Celeste
Marshall, James R.
Lambrecht, Richard W.
Pendyala, Swaroop
Kopelovich, Levy
Kim, Myungjin
Kleinstein, Steven H.
Laird, Peter W.
Lipkin, Martin
Holt, Peter R.
spellingShingle Protiva, Petr
Mason, Joel B.
Liu, Zhenhua
Hopkins, Michael E.
Nelson, Celeste
Marshall, James R.
Lambrecht, Richard W.
Pendyala, Swaroop
Kopelovich, Levy
Kim, Myungjin
Kleinstein, Steven H.
Laird, Peter W.
Lipkin, Martin
Holt, Peter R.
Cancer Prevention Research
Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
Cancer Research
Oncology
author_sort protiva, petr
spelling Protiva, Petr Mason, Joel B. Liu, Zhenhua Hopkins, Michael E. Nelson, Celeste Marshall, James R. Lambrecht, Richard W. Pendyala, Swaroop Kopelovich, Levy Kim, Myungjin Kleinstein, Steven H. Laird, Peter W. Lipkin, Martin Holt, Peter R. 1940-6207 1940-6215 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1940-6207.capr-10-0143 <jats:title>Abstract</jats:title> <jats:p>Low folate status increases colorectal cancer risk. Paradoxically, overly abundant folate supplementation, which is not uncommon in the United States, may increase risk. The mechanisms of these effects are unknown. We conducted two translational studies to define molecular pathways in the human colon altered either by folate supplementation or by dietary folate depletion (followed by repletion). In the first study, 10 healthy, at-risk volunteers (with documented stable/normal folate intake) received supplemental folic acid (1 mg/d) for 8 weeks. In the second study, 10 similar subjects were admitted to a hospital as inpatients for 12 weeks to study folate depletion induced by a low folate diet. A repletion regimen of folic acid (1 mg/d) was provided for the last 4 of these weeks. Both studies included an 8-week run-in period to ensure stabilized folate levels prior to intervention. We obtained 12 rectosigmoid biopsies (from 4 quadrants of normal-appearing mucosa 10–15 cm from the anal verge) at baseline and at measured intervals in both studies for assessing the primary endpoints: genome-wide gene expression, genomic DNA methylation, promoter methylation (depletion/repletion study only), and p53 DNA strand breaks. Serum and rectosigmoid folate concentrations accurately tracked all changes in folate delivery (P &amp;lt; 0.05). In the first study, gene array analysis revealed that supplementation upregulated multiple inflammation- and immune-related pathways in addition to altering several 1-carbon–related enzymes (P &amp;lt; 0.001). In the second study, folate depletion downregulated genes involved in immune response, inflammation, the cell cycle, and mitochondrial/energy pathways; repletion reversed most of these changes. However, changes in gene expression after repletion in the second study (involving immune response and inflammation) did not reach the levels seen after supplementation in the first study. Neither genomic nor promoter-specific DNA methylation changed during the course of the depletion/repletion protocol, and genomic methylation did not change with supplementation in the first study. p53 DNA strand breaks increased with depletion after 12 weeks. In sum, depletion downregulates, whereas repletion or supplementation upregulates pathways related to inflammation and immune response. These findings provide novel support to the concept that excessive folate supplementation might promote colorectal carcinogenesis by enhancing proinflammatory and immune response pathways. These results indicate that modest changes in folate delivery create substantial changes in the molecular milieu of the human colon. Cancer Prev Res; 4(4); 530–43. ©2011 AACR.</jats:p> Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis Cancer Prevention Research
doi_str_mv 10.1158/1940-6207.capr-10-0143
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xOTQwLTYyMDcuY2Fwci0xMC0wMTQz
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xOTQwLTYyMDcuY2Fwci0xMC0wMTQz
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint American Association for Cancer Research (AACR), 2011
imprint_str_mv American Association for Cancer Research (AACR), 2011
issn 1940-6207
1940-6215
issn_str_mv 1940-6207
1940-6215
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str protiva2011alteredfolateavailabilitymodifiesthemolecularenvironmentofthehumancolorectumimplicationsforcolorectalcarcinogenesis
publishDateSort 2011
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Cancer Prevention Research
source_id 49
title Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
title_unstemmed Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
title_full Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
title_fullStr Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
title_full_unstemmed Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
title_short Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
title_sort altered folate availability modifies the molecular environment of the human colorectum: implications for colorectal carcinogenesis
topic Cancer Research
Oncology
url http://dx.doi.org/10.1158/1940-6207.capr-10-0143
publishDate 2011
physical 530-543
description <jats:title>Abstract</jats:title> <jats:p>Low folate status increases colorectal cancer risk. Paradoxically, overly abundant folate supplementation, which is not uncommon in the United States, may increase risk. The mechanisms of these effects are unknown. We conducted two translational studies to define molecular pathways in the human colon altered either by folate supplementation or by dietary folate depletion (followed by repletion). In the first study, 10 healthy, at-risk volunteers (with documented stable/normal folate intake) received supplemental folic acid (1 mg/d) for 8 weeks. In the second study, 10 similar subjects were admitted to a hospital as inpatients for 12 weeks to study folate depletion induced by a low folate diet. A repletion regimen of folic acid (1 mg/d) was provided for the last 4 of these weeks. Both studies included an 8-week run-in period to ensure stabilized folate levels prior to intervention. We obtained 12 rectosigmoid biopsies (from 4 quadrants of normal-appearing mucosa 10–15 cm from the anal verge) at baseline and at measured intervals in both studies for assessing the primary endpoints: genome-wide gene expression, genomic DNA methylation, promoter methylation (depletion/repletion study only), and p53 DNA strand breaks. Serum and rectosigmoid folate concentrations accurately tracked all changes in folate delivery (P &amp;lt; 0.05). In the first study, gene array analysis revealed that supplementation upregulated multiple inflammation- and immune-related pathways in addition to altering several 1-carbon–related enzymes (P &amp;lt; 0.001). In the second study, folate depletion downregulated genes involved in immune response, inflammation, the cell cycle, and mitochondrial/energy pathways; repletion reversed most of these changes. However, changes in gene expression after repletion in the second study (involving immune response and inflammation) did not reach the levels seen after supplementation in the first study. Neither genomic nor promoter-specific DNA methylation changed during the course of the depletion/repletion protocol, and genomic methylation did not change with supplementation in the first study. p53 DNA strand breaks increased with depletion after 12 weeks. In sum, depletion downregulates, whereas repletion or supplementation upregulates pathways related to inflammation and immune response. These findings provide novel support to the concept that excessive folate supplementation might promote colorectal carcinogenesis by enhancing proinflammatory and immune response pathways. These results indicate that modest changes in folate delivery create substantial changes in the molecular milieu of the human colon. Cancer Prev Res; 4(4); 530–43. ©2011 AACR.</jats:p>
container_issue 4
container_start_page 530
container_title Cancer Prevention Research
container_volume 4
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792337679430451204
geogr_code not assigned
last_indexed 2024-03-01T15:19:57.615Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Altered+Folate+Availability+Modifies+the+Molecular+Environment+of+the+Human+Colorectum%3A+Implications+for+Colorectal+Carcinogenesis&rft.date=2011-04-01&genre=article&issn=1940-6215&volume=4&issue=4&spage=530&epage=543&pages=530-543&jtitle=Cancer+Prevention+Research&atitle=Altered+Folate+Availability+Modifies+the+Molecular+Environment+of+the+Human+Colorectum%3A+Implications+for+Colorectal+Carcinogenesis&aulast=Holt&aufirst=Peter+R.&rft_id=info%3Adoi%2F10.1158%2F1940-6207.capr-10-0143&rft.language%5B0%5D=eng
SOLR
_version_ 1792337679430451204
author Protiva, Petr, Mason, Joel B., Liu, Zhenhua, Hopkins, Michael E., Nelson, Celeste, Marshall, James R., Lambrecht, Richard W., Pendyala, Swaroop, Kopelovich, Levy, Kim, Myungjin, Kleinstein, Steven H., Laird, Peter W., Lipkin, Martin, Holt, Peter R.
author_facet Protiva, Petr, Mason, Joel B., Liu, Zhenhua, Hopkins, Michael E., Nelson, Celeste, Marshall, James R., Lambrecht, Richard W., Pendyala, Swaroop, Kopelovich, Levy, Kim, Myungjin, Kleinstein, Steven H., Laird, Peter W., Lipkin, Martin, Holt, Peter R., Protiva, Petr, Mason, Joel B., Liu, Zhenhua, Hopkins, Michael E., Nelson, Celeste, Marshall, James R., Lambrecht, Richard W., Pendyala, Swaroop, Kopelovich, Levy, Kim, Myungjin, Kleinstein, Steven H., Laird, Peter W., Lipkin, Martin, Holt, Peter R.
author_sort protiva, petr
container_issue 4
container_start_page 530
container_title Cancer Prevention Research
container_volume 4
description <jats:title>Abstract</jats:title> <jats:p>Low folate status increases colorectal cancer risk. Paradoxically, overly abundant folate supplementation, which is not uncommon in the United States, may increase risk. The mechanisms of these effects are unknown. We conducted two translational studies to define molecular pathways in the human colon altered either by folate supplementation or by dietary folate depletion (followed by repletion). In the first study, 10 healthy, at-risk volunteers (with documented stable/normal folate intake) received supplemental folic acid (1 mg/d) for 8 weeks. In the second study, 10 similar subjects were admitted to a hospital as inpatients for 12 weeks to study folate depletion induced by a low folate diet. A repletion regimen of folic acid (1 mg/d) was provided for the last 4 of these weeks. Both studies included an 8-week run-in period to ensure stabilized folate levels prior to intervention. We obtained 12 rectosigmoid biopsies (from 4 quadrants of normal-appearing mucosa 10–15 cm from the anal verge) at baseline and at measured intervals in both studies for assessing the primary endpoints: genome-wide gene expression, genomic DNA methylation, promoter methylation (depletion/repletion study only), and p53 DNA strand breaks. Serum and rectosigmoid folate concentrations accurately tracked all changes in folate delivery (P &amp;lt; 0.05). In the first study, gene array analysis revealed that supplementation upregulated multiple inflammation- and immune-related pathways in addition to altering several 1-carbon–related enzymes (P &amp;lt; 0.001). In the second study, folate depletion downregulated genes involved in immune response, inflammation, the cell cycle, and mitochondrial/energy pathways; repletion reversed most of these changes. However, changes in gene expression after repletion in the second study (involving immune response and inflammation) did not reach the levels seen after supplementation in the first study. Neither genomic nor promoter-specific DNA methylation changed during the course of the depletion/repletion protocol, and genomic methylation did not change with supplementation in the first study. p53 DNA strand breaks increased with depletion after 12 weeks. In sum, depletion downregulates, whereas repletion or supplementation upregulates pathways related to inflammation and immune response. These findings provide novel support to the concept that excessive folate supplementation might promote colorectal carcinogenesis by enhancing proinflammatory and immune response pathways. These results indicate that modest changes in folate delivery create substantial changes in the molecular milieu of the human colon. Cancer Prev Res; 4(4); 530–43. ©2011 AACR.</jats:p>
doi_str_mv 10.1158/1940-6207.capr-10-0143
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xOTQwLTYyMDcuY2Fwci0xMC0wMTQz
imprint American Association for Cancer Research (AACR), 2011
imprint_str_mv American Association for Cancer Research (AACR), 2011
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 1940-6207, 1940-6215
issn_str_mv 1940-6207, 1940-6215
language English
last_indexed 2024-03-01T15:19:57.615Z
match_str protiva2011alteredfolateavailabilitymodifiesthemolecularenvironmentofthehumancolorectumimplicationsforcolorectalcarcinogenesis
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 530-543
publishDate 2011
publishDateSort 2011
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Cancer Prevention Research
source_id 49
spelling Protiva, Petr Mason, Joel B. Liu, Zhenhua Hopkins, Michael E. Nelson, Celeste Marshall, James R. Lambrecht, Richard W. Pendyala, Swaroop Kopelovich, Levy Kim, Myungjin Kleinstein, Steven H. Laird, Peter W. Lipkin, Martin Holt, Peter R. 1940-6207 1940-6215 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1940-6207.capr-10-0143 <jats:title>Abstract</jats:title> <jats:p>Low folate status increases colorectal cancer risk. Paradoxically, overly abundant folate supplementation, which is not uncommon in the United States, may increase risk. The mechanisms of these effects are unknown. We conducted two translational studies to define molecular pathways in the human colon altered either by folate supplementation or by dietary folate depletion (followed by repletion). In the first study, 10 healthy, at-risk volunteers (with documented stable/normal folate intake) received supplemental folic acid (1 mg/d) for 8 weeks. In the second study, 10 similar subjects were admitted to a hospital as inpatients for 12 weeks to study folate depletion induced by a low folate diet. A repletion regimen of folic acid (1 mg/d) was provided for the last 4 of these weeks. Both studies included an 8-week run-in period to ensure stabilized folate levels prior to intervention. We obtained 12 rectosigmoid biopsies (from 4 quadrants of normal-appearing mucosa 10–15 cm from the anal verge) at baseline and at measured intervals in both studies for assessing the primary endpoints: genome-wide gene expression, genomic DNA methylation, promoter methylation (depletion/repletion study only), and p53 DNA strand breaks. Serum and rectosigmoid folate concentrations accurately tracked all changes in folate delivery (P &amp;lt; 0.05). In the first study, gene array analysis revealed that supplementation upregulated multiple inflammation- and immune-related pathways in addition to altering several 1-carbon–related enzymes (P &amp;lt; 0.001). In the second study, folate depletion downregulated genes involved in immune response, inflammation, the cell cycle, and mitochondrial/energy pathways; repletion reversed most of these changes. However, changes in gene expression after repletion in the second study (involving immune response and inflammation) did not reach the levels seen after supplementation in the first study. Neither genomic nor promoter-specific DNA methylation changed during the course of the depletion/repletion protocol, and genomic methylation did not change with supplementation in the first study. p53 DNA strand breaks increased with depletion after 12 weeks. In sum, depletion downregulates, whereas repletion or supplementation upregulates pathways related to inflammation and immune response. These findings provide novel support to the concept that excessive folate supplementation might promote colorectal carcinogenesis by enhancing proinflammatory and immune response pathways. These results indicate that modest changes in folate delivery create substantial changes in the molecular milieu of the human colon. Cancer Prev Res; 4(4); 530–43. ©2011 AACR.</jats:p> Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis Cancer Prevention Research
spellingShingle Protiva, Petr, Mason, Joel B., Liu, Zhenhua, Hopkins, Michael E., Nelson, Celeste, Marshall, James R., Lambrecht, Richard W., Pendyala, Swaroop, Kopelovich, Levy, Kim, Myungjin, Kleinstein, Steven H., Laird, Peter W., Lipkin, Martin, Holt, Peter R., Cancer Prevention Research, Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis, Cancer Research, Oncology
title Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
title_full Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
title_fullStr Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
title_full_unstemmed Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
title_short Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
title_sort altered folate availability modifies the molecular environment of the human colorectum: implications for colorectal carcinogenesis
title_unstemmed Altered Folate Availability Modifies the Molecular Environment of the Human Colorectum: Implications for Colorectal Carcinogenesis
topic Cancer Research, Oncology
url http://dx.doi.org/10.1158/1940-6207.capr-10-0143